Global Bio-chem Technology Group Company Limited (HKG:0809)
0.0740
-0.0030 (-3.90%)
May 30, 2025, 3:34 PM HKT
HKG:0809 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Revenue | 2,001 | 1,374 | 12.71 | 746.55 | 848.87 | Upgrade
|
Revenue Growth (YoY) | 45.65% | 10709.05% | -98.30% | -12.05% | -81.39% | Upgrade
|
Cost of Revenue | 1,782 | 1,330 | 4.82 | 721.29 | 779.87 | Upgrade
|
Gross Profit | 218.68 | 43.64 | 7.89 | 25.26 | 69 | Upgrade
|
Selling, General & Admin | 354.29 | 370.15 | 267.51 | 399.75 | 448.19 | Upgrade
|
Other Operating Expenses | - | - | 496.39 | 571.34 | 687.75 | Upgrade
|
Operating Expenses | 354.29 | 370.15 | 763.89 | 971.09 | 1,136 | Upgrade
|
Operating Income | -135.61 | -326.52 | -756.01 | -945.83 | -1,067 | Upgrade
|
Interest Expense | -323.4 | -750.35 | -685.18 | -831.69 | -877.77 | Upgrade
|
Interest & Investment Income | 0 | 0 | 0.02 | 0.27 | 0.4 | Upgrade
|
Earnings From Equity Investments | - | - | - | -2 | -2.33 | Upgrade
|
Currency Exchange Gain (Loss) | 4.52 | - | - | 1.02 | 13.89 | Upgrade
|
Other Non Operating Income (Expenses) | -67.38 | -237.56 | 16.22 | 80.19 | 77.24 | Upgrade
|
EBT Excluding Unusual Items | -521.87 | -1,314 | -1,425 | -1,698 | -1,856 | Upgrade
|
Merger & Restructuring Charges | - | - | - | - | -124.88 | Upgrade
|
Gain (Loss) on Sale of Investments | 14.1 | - | - | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | 1,962 | 421.87 | - | - | 296.38 | Upgrade
|
Asset Writedown | -776.12 | 7.41 | - | -36.46 | - | Upgrade
|
Other Unusual Items | 67.39 | 4,586 | - | 1,325 | -726.9 | Upgrade
|
Pretax Income | 745.62 | 3,701 | -1,425 | -409.47 | -2,411 | Upgrade
|
Income Tax Expense | -23.98 | -42.08 | -46.79 | 25.92 | 22.34 | Upgrade
|
Earnings From Continuing Operations | 769.6 | 3,743 | -1,378 | -435.39 | -2,433 | Upgrade
|
Earnings From Discontinued Operations | - | 481.47 | -141.41 | - | - | Upgrade
|
Net Income to Company | 769.6 | 4,225 | -1,520 | -435.39 | -2,433 | Upgrade
|
Minority Interest in Earnings | - | - | 76.5 | 34.59 | 3.32 | Upgrade
|
Net Income | 769.6 | 4,225 | -1,443 | -400.8 | -2,430 | Upgrade
|
Net Income to Common | 769.6 | 4,225 | -1,443 | -400.8 | -2,430 | Upgrade
|
Net Income Growth | -81.78% | - | - | - | - | Upgrade
|
Shares Outstanding (Basic) | 8,929 | 8,907 | 8,907 | 8,907 | 8,508 | Upgrade
|
Shares Outstanding (Diluted) | 26,196 | 14,080 | 8,907 | 8,907 | 8,508 | Upgrade
|
Shares Change (YoY) | 86.05% | 58.07% | - | 4.70% | 23.86% | Upgrade
|
EPS (Basic) | 0.09 | 0.47 | -0.16 | -0.04 | -0.29 | Upgrade
|
EPS (Diluted) | 0.03 | 0.29 | -0.16 | -0.04 | -0.29 | Upgrade
|
EPS Growth | -90.02% | - | - | - | - | Upgrade
|
Free Cash Flow | 76.04 | -94.24 | -94.19 | -501.02 | -43.02 | Upgrade
|
Free Cash Flow Per Share | 0.00 | -0.01 | -0.01 | -0.06 | -0.01 | Upgrade
|
Gross Margin | 10.93% | 3.18% | 62.06% | 3.38% | 8.13% | Upgrade
|
Operating Margin | -6.78% | -23.77% | -5947.64% | -126.69% | -125.69% | Upgrade
|
Profit Margin | 38.46% | 307.48% | -11352.91% | -53.69% | -286.26% | Upgrade
|
Free Cash Flow Margin | 3.80% | -6.86% | -740.98% | -67.11% | -5.07% | Upgrade
|
EBITDA | 77.05 | -43.5 | -447.63 | -567.57 | -635.18 | Upgrade
|
EBITDA Margin | 3.85% | -3.17% | - | -76.03% | -74.83% | Upgrade
|
D&A For EBITDA | 212.66 | 283.02 | 308.37 | 378.26 | 431.76 | Upgrade
|
EBIT | -135.61 | -326.52 | -756.01 | -945.83 | -1,067 | Upgrade
|
EBIT Margin | -6.78% | -23.77% | - | -126.69% | -125.69% | Upgrade
|
Updated Sep 11, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.